By proceeding, you agree to our Terms of Use and Privacy Policy.
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses and a training seminar, interactive group discussions, and networking options that help you engage with experts and solutions providers.
Explore emerging immune modulation strategies & strategies for targeting kinases.
Dive into immunomodulation, protein degraders, RNA & expanded programming on transcription factors, small molecules for cancer targets, and kinases.
Make meaningful connections with peers. Visit numerous concurrent sessions for informative presentations & lively dialogue to meet your research needs.
Connect with a focused audience. Leverage a wide range of platforms to launch products, gain exposure, collect feedback, network and generate new leads.
Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics.
Abcheck provides a unique source of therapeutic antibodies with one of the industry’s most versatile technology platforms.
HitGen is a rapidly growing biotech company with headquarters and the main research facility based in Chengdu, China and a subsidiary in the USA.
Collaborative Drug Discovery's CDD VAULT is a hosted biological and chemical database that securely manages your private and external data.
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific.
AssayQuant® mission is to support the development of more effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious conditions.
Pivot Park was founded in 2012 to provide the optimal European location for innovative pharmaceutical companies.
Charles River Associates (CRA) is a global consulting firm specializing in litigation, regulatory, financial, and management consulting.
Q² Solutions is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biospecimen and consent management solutions.
Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets.
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences.
LifeSensors, Inc. is a biotechnology company leading the development of innovative research tools and services for the ubiquitin and ubiquitin-like protein pathways.
Wuxi Biortus Biosciences Co. Ltd. is a protein-focused and innovation-driven contract research organization (CRO) committed to high-quality R&D services in support of drug discovery. Biortus has established four world-class research platforms: .
Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery.
Causaly accelerates how humans acquire knowledge and develop insights in Biomedicine.
Genovac offers a unique combination of the world’s most advanced antibody discovery tools.
The CDMO segment of the world's leading biotech company GenScript.
The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.
We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate. With operations in both China and the U.S., we strive to deploy the
We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate. With operations in both China and the U.S., we strive to deploy the best capabilities and resources available to us in
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.